Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-25-017535
Filing Date
2025-05-06
Accepted
2025-05-06 16:15:29
Documents
18
Period of Report
2025-06-26

Document Format Files

Seq Description Document Type Size
1 PRE 14A edge20046423x1_pre14a.htm   iXBRL PRE 14A 1746057
3 GRAPHIC edge20046423x1_pvpchart01.jpg GRAPHIC 183122
4 GRAPHIC edge20046423x1_pvpchart02.jpg GRAPHIC 163099
5 edge20046423x1_pc01.jpg GRAPHIC 737312
6 edge20046423x1_pc02.jpg GRAPHIC 418452
  Complete submission text file 0001140361-25-017535.txt   6704055

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA pgen-20250626.xsd EX-101.SCH 2133
20 EXTRACTED XBRL INSTANCE DOCUMENT edge20046423x1_pre14a_htm.xml XML 319878
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36042 | Film No.: 25917468
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)